EUVIMEDEUVIMED entdecken
Kommentar

APOL1 and Black Kidney Donors—Reducing Risk or Opportunity?

Adnan Sharif

JAMA Internal Medicine · 01.08.2026 · 186 (8) · 950

DOI: 10.1001/jamainternmed.2026.1004 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA Internal Medicine, erschienen am 01.08.2026. Verfasst von Adnan Sharif. Beteiligte Einrichtung: Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, United Kingdom. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, United Kingdom.
  • School of Infection, Inflammation and Immunology, University of Birmingham, United Kingdom.

Zitieren

APA

Sharif, A. (2026). APOL1 and Black Kidney Donors—Reducing Risk or Opportunity?. JAMA Internal Medicine, 186(8), 950. https://doi.org/10.1001/jamainternmed.2026.1004

Vancouver

Sharif A. APOL1 and Black Kidney Donors—Reducing Risk or Opportunity?. JAMA Internal Medicine. 2026;186(8):950. doi:10.1001/jamainternmed.2026.1004

BibTeX
@article{Sharif2026,
  author = {Sharif, Adnan},
  title = {APOL1 and Black Kidney Donors—Reducing Risk or Opportunity?},
  journal = {JAMA Internal Medicine},
  year = {2026},
  volume = {186},
  number = {8},
  pages = {950},
  doi = {10.1001/jamainternmed.2026.1004}
}
Kostenlos starten →